Effectiveness of BNT162b2 Vaccine Against Symptomatic SARS-CoV-2 Infection in Children Aged 5–11 Years in Japan During Omicron Variant Predominate Periods

Background: Although the effectiveness of BNT162b2 messenger RNA vaccines against the Omicron variant has been reported in several countries, data are limited in children living in Asian countries. Therefore, this study aimed to estimate the effectiveness of the pediatric primary two-dose monovalent...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Megumi Hara, Yuko Ohta, Naoki Fusazaki, Yoshio Hirota
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Japan Epidemiological Association 2024-05-01
coleção:	Journal of Epidemiology
Assuntos:	coronavirus disease 2019 severe acute respiratory syndrome coronavirus 2 omicron vaccine child
Acesso em linha:	https://www.jstage.jst.go.jp/article/jea/34/5/34_JE20230093/_pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!